2[2]Yamaji K,Fujimoto S,Yutani C,et al.Is the site of thrombus formation in the left atrial appendage associated with the risk of cerebral embolism? Cardiology,2002,97:104-110. 被引量：1
4[4]Molina CA,Montaner J,Arenillas JF,et al.Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.Stroke,2004,35:486-490. 被引量：1
5[5]Goldstein LB,Jones MR,Matchar DB,et al.Improving the reliability of stroke subgroup classification using the Tral of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.Stroke,2001,32:1091-1098. 被引量：1
6[6]Goldstein LB,Adams R,Becker K,et al.Primary prevention of ischemic stroke:A statement for healthcare professionals from the Stroke Council of the American Heart Association.Stroke,2001,32:280-299. 被引量：1
7[7]Bernhardt P,Schmidt H,Sommer T,et al.Atrial fibrillation-patients at high risk for cerebral embolism.Clin Res Cardiol,2006,95:148-153. 被引量：1
8[8]International Stroke Trial Collaborative Group.The International Stroke Trial (IST):a randomized trial of aspirin,subcutaneous heparin,both,or neither among 19345 patients with acute ischemic stroke.Lancet,1997,349:1569-1581. 被引量：1
9[9]Chehrazi BB,Seibert JA,Kissel P,et al.Evaluation of recombinant tissue plasminogen activator in embolic stroke.Neurosurgery,1989,24:355-360. 被引量：1
10[10]Gross CE,Raymond SJ,Howard DB.Delayed tissueplasminogen activator therapy in a rabbit model of thromboembolic stroke.Neurosurgery,1995,36:1172-1177. 被引量：1
